
Advertise on podcast: CMAJ Podcasts
Rating
5from
This podcast has
461 episodes
Language
EnglishPublisher
Canadian Medical Association JournalExplicit
No
Date created
2015/01/28
Latest episode
2026/11/02
Average duration
33 min.
Release period
15 days
Description
CMAJ Podcasts: Exploring the latest in Canadian medicine from coast to coast to coast with your hosts, Drs. Mojola Omole and Blair Bigham. CMAJ Podcasts delves into the scientific and social health advances on the cutting edge of Canadian health care. Episodes include real stories of patients, clinicians, and others who are impacted by our health care system.
Unlock CMAJ Podcasts podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Social media
Check CMAJ Podcasts social media presence
Podcast episodes
Check latest episodes from CMAJ Podcasts podcast
Designing and enforcing safe social media for children
2026/11/02
A new bill moving through Parliament aims to reduce the harms from social media for children under the age of 16. Bill C-34, the Safe Social Media Act, advances a multipronged framework for regulation. It includes restrictions on social media for children under 16 unless social media companies implement a suite of safe practices. An analysis in CMAJ examines the strengths of the Canadian model in comparison to efforts in other countries.
Dr. Charlotte Moore Hepburn, co-author of the CMAJ analysis The Safe Social Media Act: lessons from international online safety policies for protecting child health in Canada, describes the online environment as the largest unregulated experiment on child development in history. She describes real harms pediatricians see in their patients. Children admitted after suicide attempts and with advanced eating disorders, harms linked directly to what those children encountered online. She says the bill is an “elegant and nuanced” response to the issue.
Australia has enacted one of the more high-profile strategies towards social media regulation. Dr. Courtney Barnes, a research fellow with the National Centre for Implementation Science at the University of Newcastle, led a study published in the BMJ on the early effects of Australia’s Social Media Minimum Age Act. Three months in, more than 86% of adolescents under 16 still used at least one restricted platform each week, mostly through their own accounts. One of the weaknesses of the Act was that it allowed social media companies to design the access barriers. Most implemented self-declared age as the main obstacle, something that was easy for children to bypass. Dr. Barnes does not see the Act as a policy failure, and notes Australia has since strengthened its regulator’s enforcement powers and is drafting a Digital Duty of Care Act targeting platform design.
Both researchers emphasize the need for a broad spectrum of strategies. The Canadian bill remains at the early stages of the parliamentary process, offering physicians the chance to participate in the development of effective legislation.
For more information from our sponsor, go to CMPA Physician Well-Being Index.
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
One in 20 physicians live with a disability, with little support from the system
2026/10/19
One in 20 practising physicians in Canada report a disability always or often, a figure that rises to 17% when intermittent disability is included. These findings come from Prevalence and characteristics of disabilities in physicians in Canada: an analysis of Canadian Census data, a new study in CMAJ. The study is the first nationally representative estimate of disability among practising physicians, drawn from Census data. The findings should inform efforts to improve accessibility and sustainability in the physician workforce.
Dr. Michael Quon, a general internist at The Ottawa Hospital and lead author of the study, says the true figure is likely higher, given stigma within the profession and the exclusion of physicians who have already left practice. He shares his own experiences trying to reenter medicine after a brain injury and finding there were no resources or systems to help accommodate him or ease his return to hospital work.
Dr. Kendra Hebert’s article, Challenging norms: the history and future of physicians with disabilities in Canada, was published in CMAJ earlier this year. She is an internal medicine resident at Dalhousie in Saint John, New Brunswick, and she shares her experience as a wheelchair user navigating medical school and residency. She describes a general willingness to support her but a system that largely expected her to do the work of organizing her own accommodations.
With up to one in six physicians living with a disability, medical institutions need structural change, not individual goodwill, to keep these colleagues in practice. Hospitals and training programs can start by adopting clear accommodation policies and providing contacts for support.
For more information from our sponsor, Scotiabank Healthcare+ Physician Banking Program, go to md.ca/lifeplan.
For more information from our sponsor, Physician Well-Being Index, go to CMPA Physician Well-Being Index.
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
PMOS: a new name for PCOS, and why it matters
2026/10/05
Polycystic ovary syndrome, or PCOS, is shifting to a new name: polyendocrine metabolic ovarian syndrome, or PMOS. A CMAJ commentary, Polyendocrine metabolic ovarian syndrome: A new name to support better treatment, argues that the old name was framed too narrowly around fertility. The new moniker aims to place metabolic syndrome at the centre of the diagnosis.
Dr. Ginevra Mills, a reproductive endocrinologist in Victoria and author of the commentary, says PMOS is driven by systemic insulin resistance. Historically, PCOS was overly focused on ovarian dysfunction, although the condition can appear without irregular periods. About a third of patients do not have obesity. Symptoms such as hirsutism, acne and dyslipidemia were frequently downplayed. The new term widens the lens to the full suite of symptoms. Treatment is targeted at addressing the root metabolic cause.
Sarah Chambers experienced this narrow emphasis on irregular periods and fertility when she was 16. She says no physician ever discussed her metabolic health, and symptoms such as her persistent weight gain and hair on her face were largely ignored. She believes the new name would have streamlined her journey to diagnosis and would have given her a better understanding of what she was experiencing.
When a patient presents with irregular cycles, hirsutism or unexplained weight gain, physicians should screen for insulin resistance, dyslipidemia and hypertension rather than stopping at cycle control. Treatment should prioritize empathetic management of the underlying metabolic condition.
For more information from our sponsor, go to CMPA Physician Well-Being Index.
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
What drug decriminalization in British Columbia could and could not achieve
2026/09/21
On January 31, 2023, the government of British Columbia implemented a temporary, three-year drug decriminalization policy. Under the policy, adults (18 and older) could possess up to a combined 2.5 grams of specified illegal drugs—including opioids, cocaine, methamphetamine, and MDMA—for personal use without criminal charges, prosecution, or confiscation. The policy was intended to reduce the health and social harms of illicit substance use.
A new study in CMAJ evaluated changes in drug-related hospitalizations and deaths alongside police interactions such as arrests during and after the period of decriminalization. Dr. Blair Bigham and Dr. Mojola Omole speak with coauthor Dr. Daniel Myran about the study, "Impact of drug decriminalization and recriminalization on drug-related crime and health outcomes in British Columbia: a population-level time-series analysis." He explains that the policy had no impact on hospitalizations and deaths but significantly reduced police interactions.
The hosts then speak with Dr. Alexis Crabtree, coauthor of an accompanying commentary, "What decriminalization in British Columbia could and could not achieve." She explains that one goal was to reduce stigma and, in turn, increase interaction with substance use supports. Instead, she says, the policy may have increased stigma—though the reduction in police interactions alone may justify it.
Together, the authors argue there is no silver bullet for reducing the harms of substance use. Any solution will need to be multipronged and long lasting.
For more information from our sponsor, go to md.ca/lifeplan
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
ENCORE: Rising psychosis, youth mental health, and what’s driving the trend
2026/09/07
On this episode of the CMAJ Podcast, Dr. Mojola Omole and Dr. Blair Bigham explore new evidence suggesting that rates of psychotic disorders are increasing in younger generations in Canada. Drawing on population-level data and broader psychiatric research, the episode examines how generational trends in psychosis intersect with substance use, social change, and the ongoing youth mental health crisis.
Dr. Daniel Myran, a family physician and public health researcher at North York General Hospital, discusses findings from his CMAJ study, Incidence of psychotic disorders by birth cohort: a population-based cohort study in Ontario, Canada. He explains how overall rates of psychosis appear stable when populations are viewed as a whole, but mask a substantial rise among people born in the 1980s, 1990s, and early 2000s. Dr. Myran outlines possible contributors, including substance exposure, changes in diagnostic practices, and social determinants, and emphasizes the implications for early intervention psychosis programs and frontline care.
The conversation then widens with Dr. Dafna Kahana, an associate professor of psychiatry at the University of Toronto and staff psychiatrist at CAMH, who draws on her article in the Journal of Psychiatry and Neuroscience, Are the kids alright? Making sense of the current youth mental health crisis in Canada through heuristic and data. She unpacks how social media use, sleep disruption, physical inactivity, pandemic-related isolation, and exposure to global crises may interact to affect youth mental health, while cautioning against oversimplified explanations or single-factor solutions.
For clinicians, the takeaway is twofold: emerging generational shifts in psychosis warrant attention in both primary care and mental health planning, and addressing youth mental health requires a coordinated, multi-pronged approach that spans early identification, family support, and system-level investment rather than reliance on any single intervention.
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
ENCORE: Updated HIV prophylaxis guidelines: what clinicians need to know
2026/08/24
Despite a range of effective prevention tools, HIV incidence continues to rise in Canada, with stark disparities across ethnicity, gender, Indigeneity and geography. Updated Canadian guidelines on HIV pre- and post-exposure prophylaxis reflect scientific advances since 2017 and address both new formulations and persistent barriers to equitable access.
Dr. Darrell Tan, lead author and clinician scientist at St. Michael’s Hospital, outlines several prophylaxis options now available. Daily oral tenofovir disoproxil fumarate with emtricitabine is close to 100 per cent effective with perfect adherence and remains forgiving of occasional missed doses. Long-acting injectable cabotegravir, administered every two months, shows even greater effectiveness in trials largely because it reduces the adherence challenges associated with daily pills, though cost and availability continue to limit uptake.
Natasha Lawrence, a community health worker at Women’s Health in Women’s Hands Community Health Centre in Toronto, reports that most women she serves have never heard of pre-exposure prophylaxis. Many people perceive their HIV risk as low until discussions explore relationship dynamics, including uncertainty about partner fidelity or difficulty negotiating condom use. She highlights how power imbalances and gender-based violence shape women’s risk and may limit the practicality of daily pills. Long-acting injectables can offer greater privacy and autonomy for some women, reducing the risk of partner detection. Public health messaging, she stresses, must be co-designed with communities to ensure cultural relevance and avoid stigma.
Clinicians should initiate sexual health conversations routinely, not only when patients raise concerns. Pre-exposure prophylaxis can be discussed during visits for contraception, mental health or other routine care. When patients express interest, access should not be limited by rigid criteria. Long-acting options may be especially helpful for women who face safety or privacy concerns in their relationships.
For more information from our sponsor, go to md.ca/lifeplan
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
Emergency physician burnout and attrition
2026/08/10
Emergency departments across Canada are seeing record patient volumes, bed shortages and overcrowding. A new longitudinal study in CMAJ, "Emergency physician burnout and attrition in Canada: a longitudinal study," finds physician burnout now above pandemic-era levels and driving reduced hours and departures from the specialty.
Dr. Kerstin de Wit, the study's lead author, an emergency physician and Tier 1 Canada Research Chair at Queen's University, reports that 65% of respondents to the January 2025 survey had high burnout levels, slightly higher than at the pandemic peak in December 2020, a statistically significant difference. Participants described the health care system as broken, with chronic overcrowding forcing physicians to examine patients in corridors and waiting rooms as quality of care slips. Half the cohort had reduced shifts, 20% had stepped away from emergency medicine for a time, and 10% had left and not returned. She also describes physicians coping by detaching from responsibility for a situation they feel powerless to change.
Dr. Jillian Horton, associate chair of internal medicine at the University of Manitoba and author of We Are All Perfectly Fine, teaches an evidence-based program for physicians in distress. She argues that organizational factors drive 80% to 90% of burnout and individual factors closer to 10%, and that wellness efforts fail when they focus on individual-level solutions. Physicians now reject the language of resilience, she says, so she focuses on meaning, citing research that physicians who spend at least 20% of their time on the work they find most meaningful have half the burnout risk of physicians who spend less.
The study puts the cause in the system, which limits what any one physician can fix alone. Physicians can still protect the most meaningful parts of their work, which the research links to lower burnout risk.
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
The narrow promise of lecanemab for Alzheimer disease
2026/07/27
Lecanemab arrived in Canada in January 2026 as an anti-amyloid therapy meant to slow Alzheimer disease. A new practice article in CMAJ, "Lecanemab use for early Alzheimer disease in Canada," lays out key challenges with the drug including narrow eligibility, a modest effect that may not be clinically meaningful, and a resource-intensive path to treatment.
Dr. Sophie Weiss, a co-author of the article and a third-year internal medicine resident at the University of Toronto, walks through eligibility and effect size of this novel treatment. Qualifying is a multi-step process of confirmed amyloid on a PET scan or lumbar puncture, genetic testing and a baseline MRI. However, the Clarity AD trial slowed decline by 0.45 points on a standard dementia scale, short of the roughly 1-point difference considered clinically meaningful. Patients eligible and interested in pursuing the therapy, in spite of its modest benefit, will need to pay $35,000 to $40,000 a year which presents one more barrier to treatment.
Dr. Vivian Ewa, a care of the elderly physician in Calgary and a clinical associate professor at the University of Calgary, describes the drug's limited role in her practice. She is unable to prescribe it as this is restricted to a small number of specialized prescribers. She says biweekly infusions and urban-only diagnostics put it out of reach for rural and remote patients. For the many who will not qualify, she points to the 2024 Lancet Commission finding that 45% of dementia cases are potentially preventable by modifying 14 risk factors, through such interventions as physical activity, socialization, vascular risk management and hearing correction.
For some patients, lecanemab may offer hope for a devastating condition lacking effective disease-modifying treatments. Physicians should be clear about the potential barriers, modest effect size and significant cost. At the same time, primary care physicians should emphasize the impact of reducing identified risk factors.
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
Rethinking the contrast allergy label
2026/07/13
A contrast allergy note on the chart can trigger delays, unnecessary steroids and avoided scans, yet often these labels are not clinically justified. A new practice article in CMAJ, “Hypersensitivity reactions to iodinated contrast media,” examines how the labels arise and why the standard premedication rests on contrast agents that are no longer used.
Dr. Samira Jeimy, an associate professor and program director of the division of clinical immunology and allergy at Western University and an author of the article, separates adverse reactions into Type A, the dose-dependent flushing, nausea and vasovagal symptoms anyone can get, and Type B, the bizarre ones from anaphylaxis to delayed reactions such as Stevens-Johnson syndrome. She notes the weak literature behind corticosteroid premedication is based on older high-osmolality agents that modern imaging has left behind.
Dr. Amit Katyan, a radiologist at the Ottawa Hospital and its lead for CT, has built a protocol that works back through the history for signs the reaction affected airway, breathing or circulation, or required epinephrine, an emergency visit or admission. For mild and moderate reactions his team skips steroids and switches to a contrast agent the patient has not had before, an approach he says the guidelines favour.
For physicians, the first move is to reverse-engineer the label rather than act on it, since many notes describe an expected physiological reaction rather than a true allergy. A necessary contrast study should not be delayed for steroid premedication when the history points to a mild reaction and another agent can be substituted.
For more information from our sponsor, go to md.ca/lifeplan
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
Summer encore: Perspectives on the new guideline for managing obesity in children
2026/06/29
It’s been nearly two decades since the last Canadian clinical practice guideline on managing obesity in children. In that time, the science has advanced, treatment options have expanded, and the need for updated guidance has grown increasingly urgent. On this episode of the CMAJ Podcast, hosts Dr. Mojola Omole and Dr. Blair Bigham speak with three guests who contributed to or were impacted by the new guideline published in CMAJ. Together, they explore how the recommendations address the complexity of pediatric obesity and what it takes to implement them in real-world settings.
Dr. Geoff Ball, chair of the guideline steering committee, explains how the recommendations were shaped by evidence as well as the meaningful participation of parents and youth at every stage of development. He discusses how the panel weighed the benefits and risks of pharmacotherapy and bariatric surgery in the context of limited pediatric data and a rapidly evolving treatment landscape.
Dr. Michelle Jackman, a pediatrician and clinical lead at the Pediatric Centre for Wellness and Health in Calgary, shares how her team delivers multi-component behavioural interventions, often in the absence of system-wide supports. She reflects on how the new guideline has prompted her to reconsider referral pathways for bariatric surgery and advocate more strongly for patients.
Brenndon Goodman, a long-time patient advocate, offers his own experience navigating childhood obesity, including the emotional dimensions of eating, the impact of stigma, and the life-changing outcome of bariatric surgery. He calls for improved access to care and a stronger commitment to children and youth living with obesity.
This episode highlights both the progress and the persistent barriers in treating childhood obesity. The new guideline affirms that obesity is a complex chronic condition and provides much-needed support for physicians caring for children and youth living with it.
For more information from our sponsor, go to HaleonHealthPartner.com
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
Relieving the symptoms and stigma of female urinary incontinence
2026/06/15
Urinary incontinence affects about a third of adult women in Canada, yet many never receive a diagnosis or treatment. On this episode, Dr. Blair Bigham and Dr. Mojola Omole discuss the CMAJ review “Diagnosis and management of urinary incontinence in females,” which outlines how physicians can identify common forms of incontinence and begin management in primary care.
The episode opens with Sharon Roman, who shares her experience living with bladder dysfunction related to multiple sclerosis. Her story highlights the embarrassment, health consequences and barriers to care that can come with urinary incontinence, as well as the frustration of being told to simply keep living with symptoms that profoundly affect quality of life.
Dr. Louise-Helene Gagnon, an author of the review, a urogynecologist at Sunnybrook Hospital and assistant professor at the University of Toronto, explains the distinction between stress urinary incontinence and urge incontinence. She reviews common risk factors, including childbirth, menopause and pelvic floor injury, and walks through treatment options including pelvic floor physiotherapy, pessaries, mirabegron, vaginal estrogen and specialist referral.
For physicians, the central message is simple: patients may not raise urinary incontinence on their own. Asking about it directly can open the door to practical treatments that reduce isolation, embarrassment and daily disruption.
For more information from our sponsor, go to md.ca/lifeplan
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
Understanding near-death experiences
2026/06/01
Near-death experiences (NDE) are often described in spiritual, personal or even supernatural terms. But a new CMAJ article offers physicians a clinical entry point into understanding them as a distinct phenomenon that patients may report after cardiac arrest, critical illness or other life-threatening events.
Dr. Blair Bigham and Dr. Mojola Omole speak with Dr. Andrés Delgado-Ron, a senior data analyst at Simon Fraser University’s Faculty of Health Sciences and author of “Five things to know about near-death experiences”. He explains how NDEs differ from delirium or hallucinations, why they are often described as highly organized and vivid, and how veridical perceptions, where patients report details that can later be verified, raise important questions for researchers and clinicians.
They also speak with Dr. Marieta Pehlivanova, research assistant professor of psychiatry and neurobehavioural science at the University of Virginia Division of Perceptual Studies, about how physicians respond when patients disclose these experiences. She explains why dismissive reactions can be harmful, how they may prevent patients from processing an event that feels profound, and why clinicians can validate the experience without needing to explain or endorse every aspect of it.
For physicians, the message is practical: stay curious, listen without judgement and avoid automatically pathologizing or brushing aside a patient’s account. Patients may need space to talk about what happened, and clinicians can offer that space while still maintaining scientific rigour.
Lancet article discussed.
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
Endometriosis and the devastating risks of untreated disease
2026/05/18
Two articles in CMAJ look at endometriosis from sharply different angles. One shows how devastating delayed recognition can be, following a patient whose deep infiltrating endometriosis led to renal atrophy, bowel obstruction, sciatic nerve impingement and a permanent ostomy. The other offers a more reassuring picture, finding only a small increased risk of congenital anomalies among infants born to patients with endometriosis. Together, they show why endometriosis deserves earlier recognition, better imaging and more serious clinical attention.
Dr. Sony Singh, chair of the Department of Obstetrics and Gynecology at the University of Ottawa and head of the Department of Obstetrics, Gynecology and Newborn Care at The Ottawa Hospital, discusses the CMAJ practice article, “Renal atrophy, bowel obstruction, and sciatic nerve impingement secondary to endometriosis”. He explains how deep infiltrating endometriosis can invade adjacent organs and cause severe fibrosis when left untreated.
Bailey Milne, a PhD candidate in epidemiology at Queen’s University, discusses the CMAJ article, Risk of congenital anomalies for infants born to patients with endometriosis: a population-based cohort study. She emphasizes that although the study found a small increased risk of congenital anomalies, the overall risk remains low.
For physicians, the episode highlights the importance of considering endometriosis in patients with cyclical pelvic, abdominal, bowel, urinary or sexual pain, even when initial imaging is normal.
For more information from our sponsor, go to md.ca/lifeplan
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
Cancer rates improve but troubling gaps persist for younger patients
2026/05/04
While overall cancer rates in Canada continue to decline, reflecting decades of progress in screening and treatment, younger survivors face troubling gaps in their follow-up care. In the research article “Projected estimates of cancer in Canada in 2026” overall cancer incidence and mortality rates continue to decline when adjusted for population size, reflecting advances in screening, early detection, and treatment. But for adolescents and young adults, surviving cancer may mark the start of a more complex and less coordinated phase of care.
Dr. Darren Brenner, a molecular cancer epidemiologist at the University of Calgary, reports that more than 250,000 Canadians are expected to be diagnosed with cancer in 2026, with rates per 100,000 continuing to fall. Mortality has declined for several major cancers, though increases in pancreatic and uterine cancers highlight uneven progress. Brenner notes that a growing number of survivors are now living with elevated risk of second primary cancers and will require long-term follow-up.
Dr. Miranda Fidler-Benaoudia, a cancer epidemiologist at Cancer Care Alberta and co-author of the article, article “Subsequent primary neoplasm risk among survivors of cancer in adolescence and young adulthood: a population-based study from Alberta, Canada,” examines what happens after treatment for patients diagnosed between ages 15 and 39. Her study finds these survivors are twice as likely to develop a second primary cancer as their peers, often at younger ages than current screening programmes anticipate. Despite this, survivorship care is inconsistent. Patients treated in paediatric settings often receive lifelong, specialized follow-up, while those treated in adult systems may be discharged within a few years to primary care without standardized guidance or documentation. Many lack access to a family physician, and clinicians may not be equipped to manage the long-term risks associated with early cancer treatment.
For clinicians, these findings raise questions about how to manage a growing population of younger cancer survivors who face elevated risks over decades. Earlier onset of second cancers and the absence of clear follow-up pathways suggest current screening frameworks and transition practices may not be sufficient for this group.
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
Toward a cure for sickle cell disease
2026/04/20
Transformative therapies for sickle cell disease are redefining what is possible for patients, offering the potential for cure alongside substantial risks. In CMAJ, the article Transformative therapies for sickle cell disease outlines how stem cell transplant and emerging gene therapies are changing the trajectory of a condition long defined by recurrent crises, shortened life expectancy, and inequities in care.
Dr. Kareem Jamani, a haematologist and clinical associate professor at the University of Calgary, explains how stem cell transplant replaces a patient’s blood-forming system to eliminate sickling haemoglobin, offering what can reasonably be considered a cure. Outcomes are generally favourable, particularly with matched sibling donors, but risks remain, including graft-versus-host disease, infertility, rejection, and mortality that can reach 5–7% with less well-matched donors. He also outlines the role of gene therapy, which modifies a patient’s own stem cells to increase fetal haemoglobin production, resulting in a functional cure with similar improvements in quality of life.
The episode is grounded in the experience of Ufuoma Muwhen, who underwent a stem cell transplant as a teenager after years of frequent hospitalizations and functional limitations. She describes the toll of both the disease and the treatment process, as well as the shift in her daily life following transplant, including her ability to travel, exercise, and live without recurrent crises. Her account highlights the importance of wraparound supports and trust in the healthcare system.
For physicians, these therapies require balancing meaningful benefit against real risk, often early in life and under uncertainty. The discussion also underscores persistent inequities, including delayed acute care, limited access to fertility preservation, and the challenges of delivering advanced therapies within systems designed around oncology rather than chronic genetic disease.
For more information from our sponsor, go to medicuspensionplan.com
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions
Podcast sponsorship advertising
Start advertising on CMAJ Podcasts relevant audience podcasts
You may also like to advertise on these Podcasts

4.762612000
The Lawfare Podcast
The Lawfare Institute

4.7278922000
The Matt Walsh Show
The Daily Wire

4.818422000
The Cabral Concept
Dr. Stephen Cabral

4.6314191097
Wow in the World
Tinkercast

4.8121251000
Mind Pump: Raw Fitness Truth
Sal Di Stefano, Adam Schafer, Justin Andrews, Doug Egge

4.6620122000
The Dan Bongino Show
Cumulus Podcast Network | Dan Bongino

4.8167522000
The GaryVee Audio Experience
Gary Vaynerchuk

4.838332000
Entrepreneurs on Fire
John Lee Dumas of EOFire

4.736061324
The Bonfire with Big Jay Oakerson and Robert Kelly
SiriusXM

4.871801369
The Chalene Show | Diet, Fitness & Life Balance
Chalene Johnson


